UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________

FORM 8-K

___________

CURRENT REPORT

Pursuant To Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~March~~May 0729, 2018

FUTURELAND CORP.
(Exact name of registrant as specified in charter)

Colorado	000-53377	41-2230041
(State or other jurisdiction of incorporation or organization)	(Commission File Number)	(I.R.S. Employer Identification No.)

FutureLand Corp. 10901 Roosevelt Blvd, 1000c Saint Petersburg, Florida		33716
(Address of principal executive offices)		(Zip Code)

(727) 474-0221
(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐		Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐		Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐		Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐		Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

FORWARD LOOKING STATEMENTS

This Form 8-K and other reports filed by Registrant from time to time with the Securities and Exchange Commission (collectively the "Filings") contain or may contain forward looking statements and information that are based upon beliefs of, and information currently available to, Registrant's management as well as estimates and assumptions made by Registrant's management. When used in the filings the words "anticipate", "believe", "estimate", "expect", "future", "intend", "plan" or the negative of these terms and similar expressions as they relate to Registrant or Registrant's management identify forward looking statements. Such statements reflect the current view of Registrant with respect to future events and are subject to risks, uncertainties, assumptions and other factors relating to Registrant's industry, Registrant's operations and results of operations and any businesses that may be acquired by Registrant. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned.

Although Registrant believes that the expectations reflected in the forward looking statements are reasonable, Registrant cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States, Registrant does not intend to update any of the forward-looking statements to conform these statements to actual results.

Item 28.01, ~~Completion~~Other ~~of Acquisition or Disposition of Assets~~Events.

On ~~March~~May 629, 2018, AnFutureLand ~~Agreement~~Corp. ~~for~~(OTC Pinks: ~~Plan~~FUTL), a leading provider of ~~Merger~~strategic (real estate investment, grow facilities and material solutions to the ~~“Agreement”)~~medical and ~~was~~recreational ~~entered~~global bycannabis ~~Cannabis~~industry, ~~Leaf~~contracting and installation of Electrical, ~~Inc.~~Solar and Bi-Directional Antenna, announced ~~(“PCFP”~~that orit ~~“Cannabis~~has ~~Leaf”)~~re-worked the Amps Electric, Inc., a ~~Nevada~~Massachusetts ~~Corporation~~company, ~~which~~deal isto provide a ~~publicly~~viable ~~traded~~business ~~(OTC:~~opportunity ~~PCFP)~~amongst the parties involved. Amps Electric Holdings, ~~1934~~Inc., ~~Securities Act~~a ~~reporting~~Florida company, has been formed whereas FutureLand Corp is 51% owner and ~~Apotheca~~John Bianchi ~~Biosciences~~of Amps Electric, Inc. ~~(hereafter~~is ~~referred~~49% toowner. asThis ~~“ABI”~~deal orreplaces ~~“Apotheca~~the ~~Biosciences”)~~old JV with Greenleaf Holdings, LLC and Amps Electric, Inc. aand ~~Nevada~~FutureLand ~~Corporation~~Corp. ~~Such~~on ~~Agreement~~Sept. 6th, 2017. An additional, 20,000,000 shares will ~~result~~be inissued ~~the~~to ~~merger~~John ofBianchi ~~Apotheca~~for ~~Biosciences~~this ~~into~~new ~~Cannabis~~business venture. ~~Leaf~~Amps Electric, ~~with~~LLC ~~the~~is ~~Corporation to~~being ~~survive~~formed asin ~~Apotheca~~partnership ~~Biosciences~~with Amps Electric Holdings, Inc.

Cameron Cox, CEO of FutureLand Corp. said, ~~will~~"John ~~receive~~Bianchi 12is a visionary who sees things before they get here. BDA,~~000,000~~ ~~shares~~or ofBi-Directional ~~newly~~Antenna ~~issued~~work ~~common~~is becoming big ~~stock~~business ~~for~~and ~~its~~we ~~20%~~are ~~interest~~poised into ~~Apotheca~~gobble ~~Biosciences~~up much of the market share.”

~~Apotheca~~Amps ~~Biosciences~~has ~~and~~strategic ~~Cannabis~~alliance ~~Leaf~~with ~~entered~~BearCom ~~into the Merger Agreement~~to ~~where~~be ~~Cannabis~~one ~~Leaf~~of ~~agreed~~its toprimary ~~deliver~~contractors to ~~Apotheca~~do ~~Biosciences~~BDA ~~a certain issuance of sixty million~~ (~~60,000,000~~Bi-Directional Amplifier) ~~common~~work ~~shares~~throughout ~~of Cannabis~~the ~~Leaf,~~United ~~Inc~~States. ~~(the~~This ~~“Exchange~~work ~~Shares”),~~has been long in ~~exchange~~the ~~for~~making ~~all~~since ~~shares~~9/11/2001. ofDuring ~~Apotheca~~that ~~Biosciences~~time, ~~being~~first ~~acquired~~responders ~~into Cannabis~~were ~~Leaf,~~unable ~~which~~to ~~would~~hear ~~result~~the inmessages afrom ~~change~~inside inthe second ~~control~~tower ofthat ~~Cannabis~~the ~~Leaf~~first ~~with~~tower ~~such~~had ~~issuance~~dropped. ~~The~~Had ~~issuance~~they ~~will~~been ~~result~~able into ~~Apotheca Biosciences~~receive ~~being~~communication ~~the~~they ~~surviving~~could ~~company~~have ~~under~~vacated the ~~laws~~2nd tower ofbefore ~~the~~it ~~State of Nevada~~fell. ~~Under~~Legislation ~~the~~has ~~Agreement,~~been ~~upon~~put ~~closing,~~in ~~Apotheca~~place ~~Biosciences will~~to ~~receive~~ensure ~~the~~this ~~immediate~~kind ~~right to appointment~~ of ~~the~~thing ~~directors~~would ~~and~~never ~~officers~~happen ofagain. ~~the~~Now, ~~surviving~~buildings will ~~company~~be byrequired ~~the~~to ~~resignation~~install ofBDA’s ~~the existing~~to ~~director~~any ~~and~~structure ~~officer~~over of75ft ~~Cannabis~~in ~~Leaf,~~height ~~with~~including ~~the~~garage ~~simultaneous~~floors. ~~appointment~~Most owners of ~~two~~large commercial ~~directors~~structures ~~and~~need ~~officers~~to ~~being~~at ~~appointed by~~least ~~Apotheca.~~apply ~~The~~to ~~issuance~~have of the ~~60,000,000~~work ~~common~~done ~~shares~~by ofsometime ~~Cannabis~~in ~~Leaf~~2019 ~~will~~to ~~represent~~be ~~the~~in ~~controlling~~compliance. ~~interest~~Many ofare ~~Cannabis~~starting ~~Leaf,~~to ~~Inc.~~get ~~after~~the ~~such~~work ~~merger~~done ~~occurs~~now.

~~Additionally~~Amps Electric Holdings, ~~the~~Inc. ~~Parties~~along ~~have~~with BearCom ~~agreed~~is gearing up to ~~change~~supply this work to everyone that needs it. First, however, is a heart for our first responders here in the ~~name~~United ofStates ~~Cannabis~~and it is this sentiment that drives the opportunity; second is customer service and expertise to supply companies ~~Leaf,~~with ~~Inc~~the ability to ~~Apotheca~~meet ~~Biosciences,~~compliance ~~Inc.~~mandates ~~under~~in ~~Nevada~~time ~~law~~and for the greater good.

~~Apotheca~~“I ~~Biosciences~~am isproud ~~developing~~to ~~cutting-edge~~be ~~medical~~a ~~products, nutraceuticals,~~part ~~formulation~~of ~~and~~something as ~~delivery~~noble ~~technologies~~as ~~for~~making sure the ~~healthcare~~first ~~and~~responders ~~consumer~~can ~~care~~be ~~industry~~communicated with. ~~Their~~Amps ~~pipeline~~Electric ~~of products includes~~Holdings, ~~transdermal,~~Inc. ~~sublingual,~~along ~~and~~with ~~nasal~~BearCom ~~delivery~~will ~~technologies~~make a ~~for~~difference!”, ~~precise~~said ~~and~~John ~~controlled~~Bianchi, ~~dosing~~President of ~~cannabinoids~~Amps Electric Holdings, Inc.

Apotheca Biosciences is a pioneering biotech company with an emphasis in research and development in addition to the creation of high-grade nutraceuticals and cosmetics. Apothecia’s’ goal is to lay the groundwork and continue research of cannabinoid receptiveness in patients and create nutraceuticals that reflects their research.SIGNATURES

~~More~~Pursuant ~~information~~to onthe ~~Apotheca~~requirements of ~~Biosciences~~the ~~can~~Securities Exchange Act of 1934, the Registrant has duly caused this Report to be ~~found~~signed ~~at:~~on ~~http://www~~its behalf by the undersigned hereunto duly authorized.~~apothecabiosciences.com/~~

The Parties project the formal closing for the transaction to occur on May 15, 2018, with the release block of control shares. The Company will file a combined audited financial statement under SEC guidelines.

	FUTURELAND CORP.

Date: May 29, 2018	By: /s/ Cameron Cox
	Cameron Cox, Principal Executive Officer

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

	FUTURELAND CORP.
Date: March 07, 2018	By: /s/ Cameron Cox
	Cameron Cox, Principal Executive Officer

Filing Compare · FUTURELAND CORP.